ORPHA:217346
19q13.11 microdeletion syndrome
Also known as: Monosomy 19q13.11 · Del(19)(q13.11)
Query health: suspect — Only one of 2 strategies returned hits (phrase).
Publications
19
27.5th percentile
Trials
0
Interventional, condition-specific
Researchers
242
Distinct authors in sample
Gene link
—
Readiness
1/6
Stages with a signal
Clinical definition (Orphanet)
The 19q13.11 microdeletion is characterized by several major features including pre and postnatal growth retardation, slender habitus, severe postnatal feeding difficulties, microcephaly, intellectual deficit with speech disturbance, hypospadias and ectodermal presented by scalp aplasia, thin and sparse hair, eyebrows and eyelashes, thin and dry skin and dysplasic nails.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0013090
- MeSH:C567810
- UMLS:C2751651
Additional Mondo synonyms (1)
monosomy 19q13.11
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
1/6 stages with a signal
Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
19 matched papers (10 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
19
19 papers have ever been indexed under this name. For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
19 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
10 in the last 10 years · high confidence · 27.5th percentile (publications denominator)
Phrase hits: 19 · MeSH hits: 0
Who's working on it?
242
Distinct author names in 19 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Zhu Y2 papers · 2021
Department of Neuroscience, Yale School of Medicine, New Haven, CT, USA.
Papers in Europe PMC - 02Abderrehamane F1 paper · 2016
Institut de génétique médicale, Hôpital Jeanne de Flandre, CHRU Lille, France.
Papers in Europe PMC - 03Abe KT1 paper · 2018
Cytogenetic Laboratory Molecular Pathology SARAH Network of Rehabilitation Hospitals Brasília Brazil.
Papers in Europe PMC - 04
- 05Al Alam C1 paper · 2022
Pediatric Neurology department, American center for Psychiatry and Neurology, Al Ain, United Arab Emirates.
Papers in Europe PMC - 06Alesi V1 paper · 2022
Translational Cytogenomics Research Unit, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy.
Papers in Europe PMC - 07Andrieux J1 paper · 2016
Institut de génétique médicale, Hôpital Jeanne de Flandre, CHRU Lille, France.
Papers in Europe PMC - 08Aparicio C1 paper · 2016
Department of Nephrology, Hospital Infantil Universitario Niño Jesús, Av. Menéndez Pelayo, 65, 28009, Madrid, Spain.
Papers in Europe PMC - 09Arif A1 paper · 2023
Faculty of Science and Technology, University of Central Punjab (UCP), Lahore, Pakistan.
Papers in Europe PMC - 10Ballif BC1 paper · 2014Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 27 July 2026
No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.
high confidence · 36.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"19q13.11 microdeletion syndrome" OR "Monosomy 19q13.11" OR "Del(19)(q13.11)"
MeSH descriptor terms unioned into the query: Chromosome 19q13.11 Deletion Syndrome
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"19q13.11 microdeletion syndrome" OR "Monosomy 19q13.11" OR "Del(19)(q13.11)" OR "Chromosome 19q13.11 Deletion Syndrome"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: suspect — strategies attempted: phrase, mesh; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T09:49:29.587Z